Viatris Stock Plummets Over 15% Amid Earnings Miss and FDA Warning
Rosen Law Firm, a worldwide investor rights law firm, has investigated possible securities claims on behalf of Viatris Inc. (NASDAQ: VTRS) shareholders following accusations that Viatris may have provided materially false business information to the investing public. If you acquired Viatris shares, you may be eligible for reimbursement without paying any out-of-pocket fees or charges…